Literature DB >> 15883862

Endovascular treatment of persistent epistaxis due to pseudoaneurysm formation of the ophthalmic artery secondary to nasogastric tube.

Hakan Selcuk1, Nur Soylu, Sait Albayram, Dogan Selcuk, Harun Ozer, Naci Kocer, Civan Islak.   

Abstract

We present the case of a 60-year-old man with persistent epistaxis for 20 days that had started 2 weeks after removal of a nasogastric tube placed for an abdominal operation. There was no pathologic finding at selective facial and internal maxillary artery injections. An injury to the ethmoidal branches of the ophthalmic arteries or other arterial origins of bleeding was suspected. The internal carotid artery angiography revealed a pseudoaneurysm of an anterior ethmoidal branch of the left ophthalmic artery. The pseudoaneurysm was occluded with NBCA-histoacryl (25%) injection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883862     DOI: 10.1007/pl00021048

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

1.  Treatment of pseudoaneurysm of internal maxillary artery: a case report.

Authors:  Jimmy Charles Melo Barbalho; Eliardo Silveira Santos; José Maria Sampaio Menezes; Fabricio Rocha Gonçalves; Otacilio Luiz Chagas
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2010-06

2.  Bilateral Ophthalmic Artery Dissecting Aneurysms Presenting with Recurrent Epistaxis.

Authors:  Ali Al Balushi; Jacob Kitchener; Randall C Edgell
Journal:  J Vasc Interv Neurol       Date:  2017-01

Review 3.  Peripheral ophthalmic artery aneurysm.

Authors:  Liang Qiao; Handong Wang; Lei Mao; Suihua Chen; Wei Xie; Qi Wu
Journal:  Neurosurg Rev       Date:  2010-10-15       Impact factor: 3.042

4.  Clinical outcomes comparing parenteral and nasogastric tube nutrition after laryngeal and pharyngeal cancer surgery.

Authors:  Junsun Ryu; Byung-Ho Nam; Yuh-Seog Jung
Journal:  Dysphagia       Date:  2009-03-03       Impact factor: 3.438

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.